NCT05190562View on ClinicalTrials.gov

Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 6, 2021

Primary Completion Date

January 30, 2022

Study Completion Date

May 30, 2023

Conditions

Benign Migratory Glossitis

Interventions

DRUG

Zinc Sulfate 110 MG (Zinc 25 MG) Oral Tablet

Zinc sulfate is an inorganic compound. It is used as a dietary supplement to treat zinc deficiency and to prevent the condition in those at high risk

Trial Locations (1)

12345

Ain Shams University, Cairo

All Listed Sponsors

lead

mariam hamouda

OTHER

NCT05190562 - Effectiveness of Zinc Supplementation in Management of Patients With Symptomatic Benign Migratory Glossitis | Biotech Hunter | Biotech Hunter